183 related articles for article (PubMed ID: 8075885)
1. Effects of the new A2 adenosine receptor antagonist 8FB-PTP, an 8 substituted pyrazolo-triazolo-pyrimidine, on in vitro functional models.
Dionisotti S; Conti A; Sandoli D; Zocchi C; Gatta F; Ongini E
Br J Pharmacol; 1994 Jun; 112(2):659-65. PubMed ID: 8075885
[TBL] [Abstract][Full Text] [Related]
2. Binding of the radioligand [3H]-SCH 58261, a new non-xanthine A2A adenosine receptor antagonist, to rat striatal membranes.
Zocchi C; Ongini E; Ferrara S; Baraldi PG; Dionisotti S
Br J Pharmacol; 1996 Apr; 117(7):1381-6. PubMed ID: 8730729
[TBL] [Abstract][Full Text] [Related]
3. The non-xanthine heterocyclic compound SCH 58261 is a new potent and selective A2a adenosine receptor antagonist.
Zocchi C; Ongini E; Conti A; Monopoli A; Negretti A; Baraldi PG; Dionisotti S
J Pharmacol Exp Ther; 1996 Feb; 276(2):398-404. PubMed ID: 8632302
[TBL] [Abstract][Full Text] [Related]
4. Differential antagonism by 1,3-dipropylxanthine-8-cyclopentylxanthine and 9-chloro-2-(2-furanyl)-5,6-dihydro-1,2,4-triazolo(1,5-c)quinazolin-5-im ine of the effects of adenosine derivatives in the presence of isoprenaline on contractile response and cyclic AMP content in cardiomyocytes. Evidence for the coexistence of A1- and A2-adenosine receptors on cardiomyocytes.
Behnke N; Müller W; Neumann J; Schmitz W; Scholz H; Stein B
J Pharmacol Exp Ther; 1990 Sep; 254(3):1017-23. PubMed ID: 2168481
[TBL] [Abstract][Full Text] [Related]
5. Repeated treatment with adenosine A1 receptor agonist and antagonist modifies the anticonvulsant properties of CPPene.
De Sarro G; Donato Di Paola E; Falconi U; Ferreri G; De Sarro A
Eur J Pharmacol; 1996 Dec; 317(2-3):239-45. PubMed ID: 8997606
[TBL] [Abstract][Full Text] [Related]
6. Pharmacology of the highly selective A1 adenosine receptor agonist 2-chloro-N6-cyclopentyladenosine.
Monopoli A; Conti A; Dionisotti S; Casati C; Camaioni E; Cristalli G; Ongini E
Arzneimittelforschung; 1994 Dec; 44(12):1305-12. PubMed ID: 7848348
[TBL] [Abstract][Full Text] [Related]
7. Activation of multiple sites by adenosine analogues in the rat isolated aorta.
Prentice DJ; Hourani SM
Br J Pharmacol; 1996 Jul; 118(6):1509-17. PubMed ID: 8832079
[TBL] [Abstract][Full Text] [Related]
8. Adenosine A1 and A2 receptor agonists alter cardiac functions and prostacyclin release in the isolated guinea-pig heart.
Felsch A; Stöcker K; Borchard U
Eur J Pharmacol; 1994 Oct; 263(3):261-8. PubMed ID: 7843263
[TBL] [Abstract][Full Text] [Related]
9. Adenosine A2A receptors mediate the inhibitory effect of adenosine on formyl-Met-Leu-Phe-stimulated respiratory burst in neutrophil leucocytes.
Fredholm BB; Zhang Y; van der Ploeg I
Naunyn Schmiedebergs Arch Pharmacol; 1996; 354(3):262-7. PubMed ID: 8878055
[TBL] [Abstract][Full Text] [Related]
10. Further investigations into adenosine A1 receptor-mediated contraction in rat colonic muscularis mucosae and its augmentation by certain alkylxanthine antagonists.
Reeves JJ; Jarvis JE; Sheehan MJ; Strong P
Br J Pharmacol; 1995 Mar; 114(5):999-1004. PubMed ID: 7780657
[TBL] [Abstract][Full Text] [Related]
11. Characterization of P1-purinoceptors on rat duodenum and urinary bladder.
Nicholls J; Hourani SM; Kitchen I
Br J Pharmacol; 1992 Mar; 105(3):639-42. PubMed ID: 1628151
[TBL] [Abstract][Full Text] [Related]
12. 4-Amino[1,2,4]triazolo[4,3-a]quinoxalines. A novel class of potent adenosine receptor antagonists and potential rapid-onset antidepressants.
Sarges R; Howard HR; Browne RG; Lebel LA; Seymour PA; Koe BK
J Med Chem; 1990 Aug; 33(8):2240-54. PubMed ID: 2374150
[TBL] [Abstract][Full Text] [Related]
13. Failure of CGS15943A to block the hypotensive action of agonists acting at the adenosine A3 receptor.
Patel M; Sheehan MJ; Strong P
Br J Pharmacol; 1994 Nov; 113(3):741-8. PubMed ID: 7858863
[TBL] [Abstract][Full Text] [Related]
14. Effects of adenosine receptor agonists and antagonists on audiogenic seizure-sensible DBA/2 mice.
De Sarro G; De Sarro A; Di Paola ED; Bertorelli R
Eur J Pharmacol; 1999 Apr; 371(2-3):137-45. PubMed ID: 10357250
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the prejunctional adenosine receptors in the rat anococcygeus muscle.
Coates J; Green MA; Sheehan MJ; Strong P
J Pharm Pharmacol; 1994 Nov; 46(11):906-10. PubMed ID: 7897597
[TBL] [Abstract][Full Text] [Related]
16. Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives: potent and selective A(2A) adenosine antagonists.
Baraldi PG; Cacciari B; Spalluto G; Pineda de las Infantas y Villatoro MJ; Zocchi C; Dionisotti S; Ongini E
J Med Chem; 1996 Mar; 39(5):1164-71. PubMed ID: 8676354
[TBL] [Abstract][Full Text] [Related]
17. Autoradiographic comparison of the potency of several structurally unrelated adenosine receptor antagonists at adenosine A1 and A(2A) receptors.
Fredholm BB; Lindström K
Eur J Pharmacol; 1999 Sep; 380(2-3):197-202. PubMed ID: 10513579
[TBL] [Abstract][Full Text] [Related]
18. Excitatory transmitter amino acid release from the ischemic rat cerebral cortex: effects of adenosine receptor agonists and antagonists.
Simpson RE; O'Regan MH; Perkins LM; Phillis JW
J Neurochem; 1992 May; 58(5):1683-90. PubMed ID: 1348522
[TBL] [Abstract][Full Text] [Related]
19. Activation of two sites by adenosine receptor agonists to cause relaxation in rat isolated mesenteric artery.
Prentice DJ; Payne SL; Hourani SM
Br J Pharmacol; 1997 Dec; 122(7):1509-15. PubMed ID: 9421303
[TBL] [Abstract][Full Text] [Related]
20. A1 adenosine receptor inhibition of cyclic AMP formation and radioligand binding in the guinea-pig cerebral cortex.
Alexander SP; Curtis AR; Kendall DA; Hill SJ
Br J Pharmacol; 1994 Dec; 113(4):1501-7. PubMed ID: 7889308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
